Neratinib is utilized to treat a specific kind of hormone receptor-positive bosom malignant growth (bosom disease that relies upon hormones, for example, estrogen to develop) in grown-ups after treatment with trastuzumab (Herceptin) and different drugs. Neratinib is in a class of prescriptions called kinase inhibitors. It works by hindering the activity of an anomalous protein that signals malignancy cells to duplicate. This moderates or stop the spread of malignant growth cells.
Neratinib is used to treat breast cancer after treatment with certain other medications (such as trastuzumab). Neratinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.